TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 6 | 4 | 8 | 6 | -26 | 13 | 2 |
| P | %wins | 100 | 50 | 50 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/12 13:43 | 1/25/12 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Dina Dino | CA | DO | CEO,Dir | M.d | 600 | 3.00 | 0 | 200 | 40 | 699 | D | 122 | 12 | 44 | 25 | 12 | 5 | -3 | 3 | 3 | 17 | 17 | 36 | 16 | -10 |
11/14/11 19:28 | 11/11/11 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Dina Dino | CA | DO | CEO,Dir | M | 0 | 0.00 | 1 | 90 | 22 | 499 | D | 117 | 43 | 10 | 10 | 56 | -2 | 9 | -1 | 1 | 2 | 13 | 46 | 44 | 66 |
4/15/10 13:23 | 4/13/10 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Dina Dino | CA | DO | P,CEO,Di | P.d | 0 | 0.00 | 0 | 70 | New | 70 | D | -24 | 101 | -15 | -6 | -4 | 6 | 10 | 5 | 9 | -3 | 38 | 39 | 30 | 77 |
5/6/08 19:33 | 5/2/08 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Dina Dino | CA | DO | P,CEO,Di | P.m | 231 | 2.31 | 0 | 100 | 45 | 321 | D | -60 | -53 | -55 | -56 | 13 | 32 | 53 | 19 | 3 | 10 | -22 | -27 | -81 | -51 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |